Samantha Innocenti

Azienda Ospedaliero-Universitaria Careggi

Papers

1

Total Citations

18

H-Index

1

About

Samantha Innocenti is a leading researcher in nephrology and urology, with a focused expertise on renal function preservation following surgical interventions. Her most cited work centers on the early detection of acute kidney injury (AKI) and the long-term prediction of kidney function decline after partial nephrectomy. In her landmark 2023 study, she systematically compared novel biomarkers—including cystatin C, neutrophil gelatinase-associated lipocalin, and kineticGFR—against traditional serum creatinine, demonstrating that these markers can identify AKI within hours and forecast sustained eGFR decline. This contribution has garnered 18 citations and is pivotal for improving post-surgical renal outcomes. Dr. Innocenti’s research bridges critical gaps in perioperative nephrology, offering clinicians actionable tools to mitigate chronic kidney disease progression. Her work is widely recognized for its translational impact, influencing both surgical decision-making and long-term patient monitoring protocols. Through her rigorous biomarker analyses, she has established herself as a key voice in precision medicine for kidney health, with her findings regularly informing guidelines for nephron-sparing surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Novel Biomarkers for Early Detection of Acute Kidney Injury and Prediction of Long-Term Kidney Function Decline after Partial Nephrectomy
18 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Azienda Ospedaliero-Universitaria Careggi

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago